Biotechnology News

WATERTOWN, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization...

Surrozen Announces Closing of Second Tranche of March 2025 Private Placement for $95.1 Million

In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, Oct. 20,...

Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 20 oct. 2026 (GLOBE NEWSWIRE) -- Place de cotation : Euronext...

Mechelen, Belgium; October 20, 2026, 22.01 CEST; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ:...

Mechelen, België; 20 oktober 2026, 22.01 CEST; gereglementeerde informatie In het kader van het op 9 juni 2026 aangekondigde inkoopprogramma maakt Lakefront Biotherapeutics NV (Euronext &...

CAMPX interim results accepted for peer-reviewed publication, showing higher closure rates with XWRAP vs. SOC alone.

CAMBRIDGE, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...

Recognized leader in RNAi drug discovery with track record of advancing novel delivery platforms and therapeutics to drive Company’s integrin-mediated delivery platform SOUTH SAN FRANCISCO, Calif.,...

Myriad Genetics and Labcorp have entered into a definitive agreement for Myriad to sell its Prenatal Health testing business to Labcorp.